Status:

RECRUITING

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Lead Sponsor:

University of Kansas Medical Center

Conditions:

Breast Cancer

Hereditary Breast and Ovarian Cancer

Eligibility:

All Genders

Brief Summary

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Detailed Description

This study is being done to collect cancer-related information from patients with triple negative breast cancer and patients with hereditary genetic mutations. This information will help us better und...

Eligibility Criteria

Inclusion

  • Inclusion criteria include:
  • Triple Negative Breast Cancer
  • ER/PR \<10% and HER negative per current ASCO/CAP guidelines
  • Stages I-IV
  • Any age at diagnosis
  • Patient must be within 5 years of diagnosis
  • Eligible regardless of genetic testing status
  • Genetic testing recommended for patients meeting NCCN and Medicare guidelines
  • AND/OR
  • Germline mutation Carriers
  • Patients with deleterious or uncertain mutations in HBOC genes (BRCA, PTEN, P53, -PALB2 etc) are eligible regardless of type/site of cancer
  • Healthy patients harboring mutations also eligible
  • There is no time limit from the time of diagnosis of cancer and enrollment.
  • Eligible regardless of personal history of cancer
  • Exclusion Criteria include:
  • Triple Negative Breast Cancer -Patient is not within five years of diagnosis
  • Germline mutation Carriers:
  • Patient only carries a HBOC mutation that is classified as "polymorphism" of "favor polymorphism"

Exclusion

    Key Trial Info

    Start Date :

    March 22 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2026

    Estimated Enrollment :

    1500 Patients enrolled

    Trial Details

    Trial ID

    NCT02302742

    Start Date

    March 22 2011

    End Date

    December 1 2026

    Last Update

    October 6 2025

    Active Locations (11)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (11 locations)

    1

    Hays Medical Center Dreiling-Schmidt Cancer Institute

    Hays, Kansas, United States, 67601

    2

    KCCC West

    Kansas City, Kansas, United States, 66112

    3

    KCCC Overland Park

    Overland Park, Kansas, United States, 66210

    4

    Overland Park Regional Medical Center

    Overland Park, Kansas, United States, 66215

    Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry | DecenTrialz